Loading live market data…

California Resources Corp

NYSE:CRC

$52.27 USD

-$0.05 (-0.1%)

Volume
568.04K
Average Volume
814.76K
Market Capitalization
$4.64B
P/E Ratio
-10.07
Dividend Yield
3.07%
Price Target
$77.00
Year High
$71.98
Year Low
$43.25
Day High
Day Low
Payout Ratio
$-0.30
Current Ratio
$0.55
Source Headline
BKV vs. California Resources: Which U.S. Oil and Gas Producer Stock Stock Is a Better Buy in 2026?

BKV focuses on natural gas and carbon capture integration in the Eastern and Southern United States. California Resources generates significant free cash flow from its dominant position in the California energy market.

fool.com - 2026-07-14 14:39:37

California Resources Corporation Schedules Second Quarter 2026 Earnings Conference Call

LONG BEACH, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) plans to release its second quarter 2026 financial results on Monday, August 10th before market hours.

globenewswire.com - 2026-07-06 09:00:00

California Resources Corporation Announces Pricing of Private Offering of $550 Million of Senior Unsecured Notes

LONG BEACH, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (the “Company”) announced today the pricing of its private offering of $550 million in aggregate principal amount of its 7.250% senior unsecured notes due 2035 (the “Notes”) at par.

globenewswire.com - 2026-06-16 17:11:00

California Resources Corporation Announces Private Offering of $550 Million of Senior Unsecured Notes

LONG BEACH, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (the “Company”) announced today that, subject to market and other conditions, it intends to offer and sell to eligible purchasers $550 million in aggregate principal amount of senior unsecured notes due 2035 (the “Notes”).

globenewswire.com - 2026-06-16 08:21:00

California Resources: The Winds Of Change In California Finally

California Resources stands to benefit from regulatory compromise enabling thousands of new wells in Kern County while tightening offshore restrictions. CRC's merger with Berry Corporation enhances operational efficiency. Emerging discussion around using carbon capture to unlock unconventional oil in-state signals potential for future production expansion.

seekingalpha.com - 2026-06-14 06:12:21

Why Is California Resources (CRC) Up 1.2% Since Last Earnings Report?

California Resources (CRC) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-04 12:36:51

Consolidation Wave Reshapes Energy Sector: 3 Stocks Vulnerable to Acquisition, Ranked

Energy sector consolidation has accelerated through 2026 so far, with majors and large independents acquiring scale, inventory, and strategic infrastructure.

247wallst.com - 2026-06-04 11:20:27

Here's Why California Resources Corporation (CRC) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-06-04 10:51:22

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

[url="]Pfizer Inc. [/url](NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 B

gurufocus.com - 2026-05-31 09:00:00

Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026

Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in

gurufocus.com - 2026-05-30 09:00:00

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire BURLINGTON,

gurufocus.com - 2026-05-29 08:00:00

FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi

gurufocus.com - 2026-05-29 07:00:00

California Resources Starts First CO2 Injection at CCS Facility

CRC announces California's first operational carbon capture project, advancing large-scale CO2 storage and expanding the state's climate strategy.

zacks.com - 2026-05-27 11:14:10

American Cancer Society Recommends Guardant Health's Shield Blood Test in Updated Colorectal Cancer Screening Guidelines

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its FDA-approved Shield™ blood test is now included in updated Ameri

gurufocus.com - 2026-05-27 08:00:00

California Resources Corporation Achieves First CO₂ Injection at Carbon TerraVault I, a Major Milestone for Carbon Management in California

KERN COUNTY, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) has achieved the first landmark carbon dioxide (CO2) injection at Carbon TerraVault I (CTV I), a first-of-its-kind carbon capture and storage (CCS) project that will help advance California's progress toward carbon neutrality.

globenewswire.com - 2026-05-26 07:00:00

California Resources Corporation Achieves First CO₂ Injection at Carbon TerraVault I, a Major Milestone for Carbon Management in California

KERN COUNTY, Calif. , May 26, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) has achieved the first landmark carbon dioxide (CO2) injection at Carbon TerraVault I (CTV I), a first-of-its-kind carbon capture and storage (CCS) project that will help advance California's progress toward carbon neutrality.

globenewswire.com - 2026-05-26 07:00:00

Is California Resources (CRC) Stock Outpacing Its Oils-Energy Peers This Year?

Here is how California Resources Corporation (CRC) and ConocoPhillips (COP) have performed compared to their sector so far this year.

zacks.com - 2026-05-18 10:40:25

California Resources Q1 Earnings Beat on Strong Oil Prices

CRC beat Q1 adjusted EPS and revenues on strong oil pricing, even as a massive derivative mark-to-market loss pushed GAAP results into the red.

zacks.com - 2026-05-11 09:26:13

California Resources Q1 Earnings Call Highlights

California Resources NYSE: CRC reported a stronger-than-expected first quarter and raised its 2026 outlook, citing higher oil prices, improved capital efficiency, accelerated drilling plans and additional cost savings from its Berry merger.

marketbeat.com - 2026-05-09 18:07:30

CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update

- Positive data announced from Phase 1 Dose Expansion Study of varsetatug masetecan (“Varseta-M”) EpCAM PROBODY® ADC in Patients with Advanced Colorectal Cancer (CRC) - - Enrollment of 40 patients in Varseta-M Dose Optimization completed; data update expected in 2H 2026 to inform monotherapy dose selection and potential registrational trial in late line CRC - - Varseta-M Phase 1 study evaluating combination with bevacizumab is ongoing with initial data expected by 1H 2027; Phase 1/2 Varseta-M chemotherapy combination study to be initiated in 2H 2026 - - Initiation of Phase 1 expansion cohort(s) in non-CRC indications planned for 2H 2026 - - Company to host conference call today at 5 p.m. ET / 2 p.m.

globenewswire.com - 2026-05-07 16:15:00

California Resources Corporation (CRC) Q1 2026 Earnings Call Transcript

California Resources Corporation (CRC) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-06 18:41:16

California Resources Corporation (CRC) Q1 Earnings and Revenues Top Estimates

California Resources Corporation (CRC) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $1.07 per share a year ago.

zacks.com - 2026-05-05 19:05:36

California Resources Corporation Reports First Quarter 2026 Financial and Operating Results

Increasing Second Half 2026 Activity to Accelerate Development of Long Duration Oil Inventory Raising 2026E Adjusted EBITDAX Guidance by 42% Driven by Strong Oil Prices, Increased Target Synergies and Expected Operating Efficiencies LONG BEACH, Calif. , May 05, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (CRC) today reported its financial and operating results for the first quarter of 2026.

globenewswire.com - 2026-05-05 16:31:00

California Resources Corporation Reports First Quarter 2026 Financial and Operating Results

Increasing Second Half 2026 Activity to Accelerate Development of Long Duration Oil Inventory Raising 2026E Adjusted EBITDAX Guidance by 42% Driven by Strong Oil Prices, Increased Target Synergies and Expected Operating Efficiencies LONG BEACH, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (CRC) today reported its financial and operating results for the first quarter of 2026.

globenewswire.com - 2026-05-05 16:31:00

Carbon TerraVault Provides First Quarter 2026 Update

LONG BEACH, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carbon TerraVault Holdings, LLC (CTV), a carbon management subsidiary of California Resources Corporation (NYSE: CRC), today provided a first quarter 2026 update on its financial and operating results.

globenewswire.com - 2026-05-05 16:30:00

Permian Resources (PR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Permian Resources (PR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-29 11:02:30

Earnings Preview: California Resources Corporation (CRC) Q1 Earnings Expected to Decline

California Resources (CRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-28 11:01:23

Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar?

The First Trust Mid Cap Core AlphaDEX ETF (FNX) was launched on May 8, 2007, and is a passively managed exchange traded fund designed to offer broad exposure to the Mid Cap Blend segment of the US equity market.

zacks.com - 2026-04-28 07:20:44

California Resources (NYSE:CRC) Shares Down 7.9% – Time to Sell?

California Resources Corporation (NYSE: CRC - Get Free Report)'s share price dropped 7.9% on Friday. The company traded as low as $62.33 and last traded at $61.57. Approximately 55,557 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 971,280 shares. The stock had previously closed at $66.87. Analysts

defenseworld.net - 2026-04-19 03:58:54

A Look at California Resources Corp (CRC) After 6.2% Decline -- GF Value $51.27 vs Price $62.74

On April 17, 2026, California Resources Corp (CRC) shares fell 6.2% to a current price of $62.74. The stock has experienced a 52-week range of $33.85 to $71.98,

gurufocus.com - 2026-04-17 19:07:00

Get CRC Insider Trade Alerts

CRC Price Target Summary

Last Month

$70.00

1 analysts

Last Quarter

$78.33

3 analysts

Last Year

$68.94

16 analysts

All Time

$65.83

30 analysts

CRC Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-13 UBS Maintain Buy Buy
2026-06-30 Citigroup Maintain Buy Buy
2026-05-27 Mizuho Maintain Outperform Outperform
2026-05-26 Barclays Maintain Overweight Overweight
2026-05-20 Citigroup Upgrade Neutral Buy
2026-05-11 UBS Maintain Buy Buy
2026-04-13 UBS Maintain Buy Buy
2026-03-30 Citigroup Maintain Neutral Neutral
2026-03-18 Citigroup Maintain Neutral Neutral
2026-03-17 Wells Fargo Maintain Overweight Overweight
2026-03-16 Barclays Maintain Overweight Overweight
2026-03-05 UBS Maintain Buy Buy
2026-03-04 Wells Fargo Maintain Overweight Overweight
2026-03-03 Barclays Maintain Overweight Overweight
2026-01-26 UBS Maintain Buy Buy
2026-01-21 Barclays Maintain Overweight Overweight
2025-12-12 UBS Maintain Buy Buy
2025-12-12 Mizuho Maintain Outperform Outperform
2025-12-09 Wells Fargo Maintain Overweight Overweight
2025-11-10 UBS Maintain Buy Buy
2025-11-06 Barclays Maintain Overweight Overweight
2025-10-10 JP Morgan Maintain Overweight Overweight
2025-09-22 B of A Securities Maintain Buy Buy
2025-09-16 UBS Maintain Buy Buy
2025-09-16 Barclays Maintain Overweight Overweight
2025-09-15 Mizuho Maintain Outperform Outperform
2025-09-03 B of A Securities Maintain Buy Buy
2025-08-20 UBS Maintain Buy Buy
2025-08-08 UBS Maintain Buy Buy
2025-08-08 Mizuho Maintain Outperform Outperform
2025-07-17 Citigroup Maintain Neutral Neutral
2025-07-15 JP Morgan Upgrade Neutral Overweight
2025-07-14 UBS Maintain Buy Buy
2025-07-14 Mizuho Maintain Outperform Outperform
2025-05-30 Barclays Upgrade Equal Weight Overweight
2025-05-19 Citigroup Maintain Neutral Neutral
2025-05-13 Mizuho Maintain Outperform Outperform
2025-05-09 Barclays Maintain Equal Weight Equal Weight
2025-05-08 UBS Maintain Buy Buy
2025-04-29 B of A Securities Maintain Buy Buy
2025-04-23 Barclays Maintain Equal Weight Equal Weight
2025-04-11 RBC Capital Maintain Outperform Outperform
2025-04-07 Citigroup Downgrade Buy Neutral
2025-03-27 RBC Capital Maintain Outperform Outperform
2025-03-05 Barclays Maintain Equal Weight Equal Weight
2025-01-14 RBC Capital Maintain Outperform Outperform
2024-11-26 TD Cowen Maintain Buy Buy
2024-08-21 B of A Securities Upgrade Neutral Buy
2024-08-15 RBC Capital Maintain Outperform Outperform
2024-08-12 RBC Capital Maintain Outperform Outperform
2024-08-08 Barclays Maintain Equal Weight Equal Weight
2024-06-14 RBC Capital Maintain Outperform Outperform
2024-06-12 RBC Capital Maintain Outperform Outperform
2024-05-13 Mizuho Maintain Buy Buy
2024-04-23 Stifel Maintain Buy Buy
2024-03-22 Stifel Maintain Buy Buy
2024-03-22 Mizuho Maintain Buy Buy
2024-03-11 Roth MKM Maintain Buy Buy
2024-03-08 RBC Capital Maintain Outperform Outperform
2024-03-06 RBC Capital Maintain Outperform Outperform
2024-02-12 Stifel Maintain Buy Buy
2024-02-08 RBC Capital Maintain Outperform Outperform
2024-02-08 Mizuho Maintain Buy Buy
2024-01-23 Stifel Maintain Buy Buy
2024-01-05 B of A Securities Downgrade Buy Neutral
2023-12-19 RBC Capital Maintain Outperform Outperform
2023-12-01 RBC Capital Maintain Outperform Outperform
2023-09-29 Mizuho Maintain Buy Buy
2023-09-25 Mizuho Maintain Buy Buy
2023-09-21 Roth MKM Maintain Buy Buy
2023-09-18 Mizuho Maintain Buy Buy
2023-08-21 Stifel Maintain Buy Buy
2023-08-16 Mizuho Maintain Buy Buy
2023-08-14 Citigroup Maintain Buy Buy
2023-08-11 Stifel Maintain Buy Buy
2023-08-01 B of A Securities Maintain Buy Buy
2023-07-24 Stifel Maintain Buy Buy
2023-07-14 Mizuho Maintain Buy Buy
2023-05-24 Mizuho Maintain Buy Buy
2023-05-19 Mizuho Maintain Buy Buy
2023-03-30 Stifel Maintain Buy Buy
2023-03-10 Mizuho Maintain Buy Buy
2023-02-27 B of A Securities Upgrade Neutral Buy
2023-02-15 Citigroup Maintain Buy Buy
2023-01-31 RBC Capital Maintain Outperform Outperform
2023-01-27 Mizuho Maintain Buy Buy
2023-01-10 Mizuho Maintain Buy Buy
2022-11-15 B of A Securities Upgrade Underperform Neutral
2022-10-20 Stifel Maintain Buy Buy
2022-07-19 B of A Securities Downgrade Buy Underperform
2022-05-10 Citigroup Maintain Buy Buy
2022-04-08 Keybanc Maintain Overweight Overweight
2022-01-20 Keybanc Maintain Overweight Overweight
2021-11-03 Keybanc Maintain Overweight Overweight
2021-10-19 Keybanc Maintain Overweight Overweight
2021-09-22 MKM Partners Maintain Buy Buy
2021-09-16 Keybanc Maintain Overweight Overweight
2021-09-08 RBC Capital Maintain Outperform Outperform
2021-05-28 RBC Capital Maintain Outperform Outperform
2020-11-25 Susquehanna Maintain Neutral Neutral
2020-11-25 Bank of America Upgrade Underperform Neutral
2020-11-25 Bank of America Maintain Buy Buy
2020-11-25 Morgan Stanley Upgrade Underweight Equal Weight
2020-11-25 Goldman Sachs Upgrade Sell Neutral
2020-11-25 Societe Generale Downgrade Buy Hold
2020-11-25 Imperial Capital Maintain In Line In Line
2020-11-25 Morgan Stanley Maintain Equal Weight Equal Weight
2020-11-25 Bank of America Downgrade Buy Neutral
2020-11-25 Imperial Capital Downgrade Outperform In Line
2020-11-25 Raymond James Upgrade Market Perform Outperform
2020-11-25 Raymond James Downgrade Outperform Perform
2020-11-25 Goldman Sachs Downgrade Neutral Sell
2020-11-25 Imperial Capital Upgrade In Line Outperform
2020-03-25 Imperial Capital Downgrade Outperform In Line
2020-03-17 Raymond James Downgrade Outperform Market Perform
2020-03-17 Raymond James Downgrade Outperform Perform
2019-07-23 B of A Securities Maintain Neutral Neutral
2019-07-23 Bank of America Maintain Neutral Neutral
2019-05-13 Raymond James Upgrade Market Perform Outperform
2019-04-12 Goldman Sachs Downgrade Neutral Sell
2019-03-29 Mizuho Maintain Buy Buy
2018-09-21 Evercore ISI Group Maintain Outperform Outperform
2018-05-17 Imperial Capital Maintain Outperform Outperform
2018-05-04 B of A Securities Maintain Buy Buy
2018-05-04 Bank of America Maintain Buy Buy
2018-04-27 Societe Generale Downgrade Buy Hold
2018-02-12 Imperial Capital Upgrade In Line Outperform
2018-02-01 Goldman Sachs Upgrade Sell Neutral
2018-01-16 Bank of America Upgrade Neutral Buy
2018-01-16 B of A Securities Upgrade Neutral Buy
2018-01-04 Bank of America Upgrade Underperform Neutral
2018-01-04 B of A Securities Upgrade Underperform Neutral
2018-01-04 Societe Generale Downgrade Buy Hold
2017-11-08 Imperial Capital Maintain In Line In Line
2017-11-07 Morgan Stanley Upgrade Equal Weight Overweight
2017-10-18 Morgan Stanley Maintain Equal Weight Equal Weight
2017-10-03 Imperial Capital Maintain In Line In Line
2017-06-30 B of A Securities Downgrade Neutral Underperform
2017-06-30 Bank of America Downgrade Neutral Underperform
2016-11-22 Morgan Stanley Upgrade Underweight Equal Weight
2016-03-02 Societe Generale Downgrade Buy Hold
2016-02-23 Bank of America Downgrade Buy Neutral
2016-02-23 B of A Securities Downgrade Buy Neutral
2016-01-26 Susquehanna Maintain Neutral Neutral
2015-10-30 Susquehanna Maintain Neutral Neutral
2015-09-25 Johnson Rice Maintain Accumulate Buy
2015-07-14 Societe Generale Maintain Buy Buy
2015-06-08 Goldman Sachs Maintain Sell Sell
2015-04-16 BTIG Research Maintain Buy Buy
2014-12-04 Raymond James Maintain Market Perform Perform